The Buteyko method was developed by Soviet physician Konstantin Buteyko in the 1950s as a treatment for asthma. The core thesis: chronic over-breathing — taking more breaths and bigger breaths than the body actually needs — is the upstream cause of a wide range of symptoms, and deliberately reducing breath volume retrains the body’s CO2 tolerance and improves multiple downstream outcomes.
The clinical evidence for Buteyko in asthma is meaningful — multiple controlled trials show reduced bronchodilator use and improved symptom scores. The application beyond asthma — to anxiety, sleep, athletic performance — is plausible but less well-validated. The technique is aligned with HRV-focused practice on several axes; it’s worth understanding even if you’re not asthmatic.
The core protocol
Buteyko practice is built around three principles: nasal breathing always, light breathing rather than deep, and deliberate breath-holds to raise CO2 tolerance.
The Control Pause (CP).The diagnostic measurement in Buteyko practice. Sit upright. Exhale normally. Pinch your nose closed. Time how long until you feel the first definite urge to breathe — not the “maximum hold time,” just the first clear signal. Release. Resume normal nasal breathing. The number of seconds is your CP.
Healthy CO2 tolerance in Buteyko terms is a CP of 40+ seconds. Most untrained adults are in the 15–25 second range. The protocol claims that raising your CP through daily practice produces measurable health improvements.
Reduced breathing exercises.The training protocol. Sit comfortably. Breathe through the nose, but deliberately smaller than normal — less air per breath, fewer breaths per minute. The target is a slight, sustained “air hunger” — feeling like you’re not getting enough air, but never to the point of strain. Continue for 5–10 minutes. Repeat several times per day.
Mouth taping at night.Some Buteyko practitioners advocate taping the mouth closed during sleep to enforce nasal breathing. Mainstream sleep medicine is split on this; there’s some evidence it reduces snoring in mild cases and no strong evidence of harm in healthy adults. Sleep apnea patients should consult their physician before adopting this.
The CO2 tolerance argument
The Buteyko mechanism centers on CO2 chemistry. Most adults slightly over-breathe — taking in more air than oxygen demand requires, which means they exhale CO2 faster than CO2 is produced. Chronic mild hyperventilation lowers arterial CO2 below the physiological optimum. Several downstream consequences follow.
Low CO2 causes vasoconstriction — blood vessels narrow, reducing tissue perfusion. It also shifts the oxygen-hemoglobin dissociation curve such that oxygen is held more tightly by hemoglobin, paradoxically reducing oxygen delivery to tissues even though more air is moving. This is the Bohr effect, and it’s textbook physiology. Buteyko’s claim is that most modern adults live in a state of mild chronic CO2 depletion, and retraining the body to tolerate higher CO2 improves nearly every aerobic outcome.
The mechanism is physiologically real. Whether the practical application — light breathing exercises — produces clinically meaningful improvements in non-asthmatic populations is less settled. The strongest evidence is still for asthma; everything else is suggestive.
What the evidence shows
Asthma.Multiple controlled trials, including randomized comparisons against standard care, show Buteyko practice reduces inhaler use, improves symptom scores, and modestly improves lung function in adults with mild-to-moderate asthma. The Cochrane reviews on the topic conclude the evidence is “promising but limited.” The Australian Asthma Council formally recognizes Buteyko as a complementary therapy.
Anxiety and panic disorder. Several small studies suggest Buteyko reduces panic attack frequency and severity in people whose panic includes a hyperventilation component. The mechanism is plausible — anxious adults often over-breathe, and the symptoms of hyperventilation (tingling, lightheadedness, depersonalization) feed the panic cycle. Stronger evidence-base needed.
Sleep and snoring. Modest evidence for reduced snoring and improved sleep quality in some studies. Mouth taping appears to be the main intervention driving the effect.
Athletic performance.Patrick McKeown (a prominent Buteyko proponent) has advocated for endurance athlete applications. The mechanism — improved oxygen offloading via CO2 tolerance — is real, but controlled trials in athletic populations are sparse and effect sizes modest. The strongest athletic application is nasal breathing during zone 2 training, which Buteyko provides a framework for but doesn’t uniquely own.
Why Buteyko aligns with HRV practice
The methods overlap in fundamentals. Both emphasize nasal breathing. Both involve slow, deliberate breath pacing. Both train autonomic regulation over weeks rather than producing instant effects. Both have measurable physiological consequences that show up in objective data.
The difference is the primary outcome variable. Buteyko targets CO2 tolerance directly and measures it via the Control Pause. Resonance breathing targets autonomic balance directly and measures it via HRV. The two protocols produce overlapping but not identical benefits, and many people who train one find the other improves along with it.
Practical translation: if you do daily resonance breathing, your CP almost certainly rises over weeks because the slow breathing rate trains both metrics. If you do daily Buteyko practice, your HRV likely climbs as a side effect because the slow nasal pattern trains vagal tone. The protocols are complementary rather than competitive.
When Buteyko is the right pick over resonance
- Asthma or chronic mild dyspnea. The strongest evidence base. Buteyko has decades of clinical tradition in this application.
- Habitual mouth breather. If you breathe through your mouth more than 50% of the day, switching to predominantly nasal breathing is a meaningful change in itself. Buteyko provides the structured protocol for the transition.
- Hyperventilation syndrome or panic with breathing component. Mechanism-targeted intervention for the underlying over-breathing.
- Endurance athlete focusing on CO2 tolerance. The aerobic application makes physiological sense and aligns with current zone 2 training thinking.
For general HRV optimization in non-asthmatic adults, resonance breathing has a larger documented effect per minute spent and is easier to learn. For someone with a specific use case above, Buteyko is a legitimate primary protocol.
Why HRV Breathe doesn’t include Buteyko
The Buteyko protocol requires the deliberate air-hunger sensation that’s central to its training stimulus. That’s difficult to deliver through a visual breath pacer — the pacer can’t enforce light breathing, only slow breathing. The methods need a different teaching model than the one HRV Breathe uses.
If you’re interested in Buteyko specifically, Patrick McKeown’s book The Oxygen Advantage is the most accessible modern treatment. The Buteyko Clinic International runs structured online courses. Combine with daily resonance breathing in HRV Breathe and you have a complementary stack that addresses both CO2 tolerance and autonomic flexibility.